Significant declines in antibody levels or concerning numbers of breakthrough infections in vaccinated individuals should spur consideration for booster doses of currently authorized COVID-19 vaccines, members of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices said.
At a 23 June meeting, ACIP was asked what data would be needed to move forward with booster recommendations, and...